Compare Danasupra Erapacific Tbk. (DEFI) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Danasupra Erapacific Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Danasupra Erapacific Tbk. trades at Rp106 (market cap 72.85B, 48.16M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp246 (market cap 167.37B, 71K 24h volume). The key difference: Brigit Biofarmaka Teknologi Tbk. is far larger — about 2.3× Danasupra Erapacific Tbk.'s market cap, and Danasupra Erapacific Tbk. is more actively traded (48.16M versus 71K). Which is the better fit depends on your goals.
| DEFI | OBAT | |
|---|---|---|
Market Cap | 72.85B | 167.37B |
Volume | 48.16M | 71K |
Lot | 481.58K | 710 |
Turnover | 5.24B | 17.51M |
Average Price | 108.75 | 246.63 |
Value | 5.24B | 17.51M |
Indicative Equilibrium Price | 106 | 246 |
Indicative Equilibrium Volume | 2.16K | 1 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Danasupra Erapacific Tbk.
Danasupra Erapacific Tbk PT. (The "Company") was established by notarial act Elliza, SH. no 65 dated 11 November 1994. Articles of the company has been approved by the Ministry of Justice of the Republic of Indonesia in its Decision Letter. C2-1.101.HT.01.01.Th.95 dated January 25, 1995. Based on the Notary Act Refizal, SH. 12, dated January 18, 2000 the company made changes to the status of the company closed to open company, authorized capital, change in nominal value of shares and public offering through the stock market. Articles of Association was approved by the Minister of Law and Legislation of the Republic of Indonesia in its Decision Letter. C-1248.HT.01.04.Th.2000 dated February 3, 2000.Accordance with Article 3 Articles of Association, the scope of its business is run financing activities which include consumer finance, factoring and leasing.
Read more on DEFI →About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →
